ReviewStem cell reviews and reports2026
Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes.
Zahid Yaseen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.